Detalles de la búsqueda
1.
Optima TB: A tool to help optimally allocate tuberculosis spending.
PLoS Comput Biol;
17(9): e1009255, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570767
2.
Covasim: An agent-based model of COVID-19 dynamics and interventions.
PLoS Comput Biol;
17(7): e1009149, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310589
3.
Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in Australia.
Clin Infect Dis;
66(7): 1019-1023, 2018 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29099920
4.
Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study.
Lancet Glob Health;
12(3): e478-e490, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365418
5.
Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic Models.
J Acquir Immune Defic Syndr;
95(1S): e59-e69, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180739
6.
Modelling to inform next-generation medical interventions for malaria prevention and treatment.
Commun Med (Lond);
3(1): 41, 2023 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36966272
7.
Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts.
Sci Rep;
13(1): 1398, 2023 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36697434
8.
Health and economic benefits of achieving contraceptive and maternal health targets in Small Island Developing States in the Pacific and Caribbean.
BMJ Glob Health;
8(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750273
9.
Public health benefits of shifting from hospital-focused to ambulatory TB care in Eastern Europe: Optimising TB investments in Belarus, the Republic of Moldova, and Romania.
PLOS Glob Public Health;
3(6): e0001025, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343015
10.
Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models.
Lancet Glob Health;
11(2): e244-e255, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36563699
11.
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups.
Infect Dis Ther;
11(5): 2045-2061, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094720
12.
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden.
Commun Med (Lond);
2: 93, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35899148
13.
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.
Epidemics;
38: 100535, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34923396
14.
The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant Plasmodium falciparum.
Elife;
112022 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35796430
15.
Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
PLoS One;
17(5): e0268240, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617169
16.
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
Lancet Glob Health;
10(9): e1298-e1306, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961353
17.
Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis.
Lancet HIV;
9(1): e42-e53, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34895484
18.
Impacts of COVID-19-related service disruptions on TB incidence and deaths in Indonesia, Kyrgyzstan, Malawi, Mozambique, and Peru: Implications for national TB responses.
PLOS Glob Public Health;
2(3): e0000219, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36962192
19.
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
Lancet HIV;
9(5): e353-e362, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489378
20.
The risks and benefits of providing HIV services during the COVID-19 pandemic.
PLoS One;
16(12): e0260820, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34941876